Endovascular Versus Medical Treatment for the Pelvic Congestion Syndrome
Status:
Not yet recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
Compare the efficacy and safety of endovascular treatment with sandwich technique (controlled
release coils and 2% polidocanol foam) associated with diosmin-hisperidine and ibuprofen
medical treatment and only the best chronic medical treatment available diosmin-hisperidine
and ibuprofen for 3 months, in women of active gynecological age carrying pelvic congestion
syndrome in public assistance in Montevideo, Uruguay.
Phase:
Phase 4
Details
Lead Sponsor:
Hospital de Clínicas Dr. Manuel Quintela
Collaborators:
Centro Cardiovascular Universitario Centro Hospitalario Pereyra Rossell University of the Republic, Uruguay